Market Analysis — UPMC LITITZ
PA market | 5 hospitals | HHI: 5,724 (Concentrated)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
5
Hospitals in Market
956
Total Beds
$1.8B
Market Revenue
Concentrated
HHI: 5,724
None
Moat Rating (2/10)
#3
Market Share Rank
Competitive Moat (Mauboussin Framework)
Based on "Measuring the Moat" adapted for healthcare. Score 0-10: wide (8+), narrow (5-7), none (<5).
Scale Advantageweak
Switching Costslow
Market Share6.3%
Top 3 Concentration96.1%
Network Density0.52
Margin vs Market+3.3%
Bed Util vs Market+9.7%
What This Means
This hospital has a none moat — no moat — commoditized market position, pricing power limited. The PA market is highly concentrated — few dominant players, potential antitrust concerns (HHI: 5,724).
Implications: Operational improvements are the primary value driver — see the EBITDA bridge. Compare against peers via comparables or see the full PA market.
Top Competitors
| Hospital | Beds | Revenue | Rev Share | Bed Share |
|---|---|---|---|---|
| LANCASTER GENERAL HOSPITAL | 620 | $1,330M | 73.6% | 64.8% |
| EPHRATA COMMUNITY HOSPITAL | 115 | $292M | 16.2% | 12.0% |
| LANCASTER BEHAVIORAL HEALTH HOSPITAL | 126 | $43M | 2.4% | 13.2% |
| LANCASTER REHABILITATION HOSPITAL | 59 | $28M | 1.6% | 6.2% |
Regional Payer Mix
■ Medicare 30%■ Medicaid 2%■ Commercial 68%